In both TCGA‐LUAD, in the GSE30219 and GSE18842 cohorts, the expression of ADRB1, ADGRD1, and ADGRE3 were reduced, whereas the expression of OR51E1 and LGR4 were elevated in tumor samples (Figure 6A). Here, ADGRE3 is linked to neoplasm.